BMY vs OFLX · P/E 17, rev $24.46B vs P/E 23, rev $47.1M
Bristol-Myers Squibb Company (BMY) versus Omega Flex Inc (OFLX) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Omega Flex Inc (OFLX) is a specialty industrial machinery company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported OFLX revenue for 2026-06-30 was $47.1M. Net income was $4.8M. OFLX currently screens at market cap $304.0M and trailing P/E 22.6.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. OFLX currently screens at market cap $304.0M and trailing P/E 22.6.
Not investment advice. Open the BMY and OFLX stock pages for the full models.
Not investment advice.